Stock Review for Health Care Plans Investors -- CVS Health, Molina Healthcare, UnitedHealth, and Humana

Thursday, December 7, 2017 General News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, Dec. 7, 2017 /PRNewswire/ --

In keeping with the commitment to dynamically provide members with timely

information, has issued free tailored Stock Review on CVS, MOH, UNH, and HUM which is a click away at On Wednesday, December 06, 2017, the NASDAQ Composite
ended the trading session at 6,776.38, up 0.21%; the Dow Jones Industrial Average edged 0.16% lower, to finish at 24,140.91; and the S&P 500 closed at 2,629.27, slightly dropping 0.01%. US markets saw four out of nine sectors finishing the day in green and five in red. This Thursday, has initiated reports coverage on the following Health Care Plans equities: CVS Health Corp. (NYSE: CVS), Molina Healthcare Inc. (NYSE: MOH), UnitedHealth Group Inc. (NYSE: UNH), and Humana Inc. (NYSE: HUM). Sign up today for free and learn why our members refer to our research coverage as the 'best out there':

CVS Health

Woonsocket, Rhode Island headquartered CVS Health Corp.'s stock finished Wednesday's session 0.52% higher at $71.38 with a total trading volume of 12.36 million shares, which was above its three months average volume of 8.57 million shares. The Company's shares have advanced 6.86% in the last month. The stock is trading below its 50-day moving average by 2.79%. Additionally, shares of CVS Health, which together with its subsidiaries, provides integrated pharmacy health care services, have a Relative Strength Index (RSI) of 48.52.

On December 04th, 2017, research firm Needham reiterated its 'Buy' rating on the Company's stock with an increase of the target price from $79 a share to $85 a share. Signing up now gives you access to the free research coverage on CVS at:

Molina Healthcare

On Wednesday, shares in Long Beach, California headquartered Molina Healthcare Inc. recorded a trading volume of 819,100 shares. The stock ended the session 2.90% lower at $74.29. The Company's shares have advanced 14.35% in the previous three months, 38.39% over the last twelve months, and 36.91% on an YTD basis. The stock is trading above its 50-day and 200-day moving averages by 5.24% and 18.53%, respectively. Moreover, shares of Molina Healthcare, which provides Medicaid-related solutions to meet the health care needs of low-income families and individuals; and to assist state agencies in their administration of the Medicaid program in the US, have an RSI of 48.49. Get access to our top-rated research, including the free report on MOH at:

UnitedHealth Group

Minnetonka, Minnesota-based UnitedHealth Group Inc.'s shares closed the day 0.07% lower at $219.94. The stock recorded a trading volume of 2.39 million shares. The Company's shares have gained 10.99% over the previous three months, 39.80% over the last twelve months, and 37.43% since the start of the year. The stock is trading above its 50-day and 200-day moving averages by 6.13% and 17.39%, respectively. Additionally, shares of UnitedHealth, which operates as a diversified health and well-being company in the US, have an RSI of 60.89. Click here to subscribe for a free membership which welcomes you with our report on UNH at:


Shares in Louisville, Kentucky headquartered Humana Inc. finished 1.20% lower at $250.30. The stock recorded a trading volume of 1.19 million shares. The Company's shares have advanced 22.52% over the last twelve months and 22.68% on an YTD basis. The stock is trading above its 50-day and 200-day moving averages by 1.95% and 6.61%, respectively. Furthermore, shares of Humana, which together with its subsidiaries, operates as a health and well-being company in the US, have an RSI of 54.48.

On November 09th, 2017, research firm RBC Capital Markets reiterated its 'Sector Perform' rating on the Company's stock with a decrease of the target price from $245 a share to $242 a share. Join our big investor community at Wall St. Equities today and start so with your free report on HUM at:


Wall St. Equities:

Wall St. Equities (WSE) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. WSE has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below. 

WSE has not been compensated; directly or indirectly; for producing or publishing this document. 


The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third-party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by WSE. WSE is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.  


WSE, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. WSE, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, WSE, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice. 


This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither WSE nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit


For any questions, inquiries, or comments reach out to us directly. If you're a company, we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: Phone number: +21-32-044-483 Office Address: 1 Scotts Road #24-10, Shaw Center Singapore 228 CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.


View original content:

SOURCE Wall St. Equities


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store